HIV-1-infection
Showing NaN - NaN of 11
HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk
Recruiting
- HIV-1-infection
- COVID-19
- COVID-19
- HIV-1 infection
-
Brussels, Belgium
- +28 more
Aug 2, 2022
HIV-1-infection Trial in London (ConM SOSIP, EDC ConM SOSIP, ConS UFO)
Active, not recruiting
- HIV-1-infection
- ConM SOSIP
- +4 more
-
London, United KingdomNIHR Imperial Clinical Resarch Facility
Jul 25, 2022
HIV-1-infection, Inflammation, AIDS Trial in Worldwide
Not yet recruiting
- HIV-1-infection
- +2 more
-
Brussels, Belgium
- +24 more
Jun 13, 2022
HIV-1-infection Trial in Worldwide (Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy)
Active, not recruiting
- HIV-1-infection
- Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy
-
Antwerp, Belgium
- +28 more
May 23, 2022
SARS-CoV-2 Antibody PrevalencE inAdult London HIV Cohort
Recruiting
- HIV-1-infection
- +2 more
-
London, United KingdomRoyal Free London NHS Foundation Trust
Oct 6, 2021
HIV-1-infection Trial in London (BIKTARVY 50Mg-200Mg-25Mg Tablet)
Not yet recruiting
- HIV-1-infection
- BIKTARVY 50Mg-200Mg-25Mg Tablet
-
London, United KingdomChelsea & Westminster Hospital NHS Foundation Trust
Jun 24, 2021
HIV-1-infection Trial in London (Doravirine, Dolutegravir, Triple cART regimen)
Not yet recruiting
- HIV-1-infection
- Doravirine
- +2 more
-
London, United KingdomChelsea & Westminster Hospital NHS Foundation Trust
Jun 23, 2021
HIV-1-infection Trial in London (Dolutegravir)
Not yet recruiting
- HIV-1-infection
-
London, United KingdomChelsea & Westminster Hospital NHS Foundation Trust
Jun 23, 2021
HIV-1-infection Trial in Lausanne, London (biological, drug, other)
Terminated
- HIV-1-infection
- GTU-MultiHIV B-clade vaccine + MVA HIV-B HIV vaccine
- +3 more
-
Lausanne, Switzerland
- +1 more
Aug 27, 2019